Lista de obras - Ann Westman-Brinkmalm - Dominio Público Uruguay

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease

scientific article published on 05 December 2018

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

artículo científico publicado en 2017

A novel pathway for amyloid precursor protein processing

artículo científico publicado en 2009

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

artículo científico publicado en 2006

Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry

artículo científico publicado en 2005

CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia

scientific article published on 17 December 2019

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

artículo científico publicado en 2022

Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy

artículo científico publicado en 2018

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

artículo científico publicado en 2007

Characterization of tau in cerebrospinal fluid using mass spectrometry

artículo científico publicado en 2008

Clinical mass spectrometry in neuroscience. Proteomics and peptidomics

artículo científico publicado en 2003

Clinical proteomics in neurodegenerative disorders

artículo científico publicado en 2008

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

artículo científico publicado en 2003

Comparative proteome analysis of thalamus in MK-801-treated rats

artículo científico publicado en 2004

Comparison of preparative and analytical two-dimensional electrophoresis for isolation and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometric analysis of transthyretin in cerebrospinal fluid

artículo científico publicado en 2002

Cystatin C in cerebrospinal fluid and multiple sclerosis

artículo científico publicado en 2007

Demonstration of multiple novel glycoforms of the stem cell survival factor CCg.

artículo científico publicado en 2004

Detection of α-Synuclein in Biological Samples Using Mass Spectrometry

artículo científico publicado en 2019

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

artículo científico publicado en 2006

Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease

artículo científico publicado en 2009

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

scientific article published on 14 September 2019

Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment

artículo científico publicado en 2007

Explorative and targeted neuroproteomics in Alzheimer's disease

artículo científico publicado en 2015

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

artículo científico publicado en 2018

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid

artículo científico publicado en 2009

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

artículo científico publicado en 2009

Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method

artículo científico publicado en 2011

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry

artículo científico publicado en 2002

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

artículo científico publicado en 2017

Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease

scientific article published on 15 April 2019

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

artículo científico publicado en 2013

P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

artículo científico publicado en 2001

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

artículo científico publicado en 2002

Proteome analysis of conditioned medium from cultured adult hippocampal progenitors ⬇️

artículo científico publicado el 1 de enero de 2003

Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update

artículo científico publicado en 2017

Proteomics and peptidomics in neuroscience. Experience of capabilities and limitations in a neurochemical laboratory.

artículo científico publicado en 2005

Proteomics profiling of single organs from individual adult zebrafish

artículo científico publicado en 2010

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

artículo científico publicado en 2009

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration

artículo científico publicado en 2011

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

artículo científico publicado en 2014

Separation Methods

artículo científico publicado en 2008

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid

artículo científico publicado en 2011

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

artículo científico publicado en 2013

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

artículo científico publicado en 2002

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

artículo científico publicado en 2016

Targeting synaptic pathology with a novel affinity mass spectrometry approach

artículo científico publicado en 2014

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

artículo científico publicado en 2016

α-Synuclein in Neurodegeneration-A Good Protein that may go Bad.

artículo científico publicado en 2016

Lista de obras de Ann Westman-Brinkmalm

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

A novel pathway for amyloid precursor protein processing

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry

CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

Characterization of tau in cerebrospinal fluid using mass spectrometry

Clinical mass spectrometry in neuroscience. Proteomics and peptidomics

Clinical proteomics in neurodegenerative disorders

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

Comparative proteome analysis of thalamus in MK-801-treated rats

Comparison of preparative and analytical two-dimensional electrophoresis for isolation and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometric analysis of transthyretin in cerebrospinal fluid

Cystatin C in cerebrospinal fluid and multiple sclerosis

Demonstration of multiple novel glycoforms of the stem cell survival factor CCg.

Detection of α-Synuclein in Biological Samples Using Mass Spectrometry

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment

Explorative and targeted neuroproteomics in Alzheimer's disease

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

Proteome analysis of conditioned medium from cultured adult hippocampal progenitors ⬇️

Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update

Proteomics and peptidomics in neuroscience. Experience of capabilities and limitations in a neurochemical laboratory.

Proteomics profiling of single organs from individual adult zebrafish

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

Separation Methods

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

Targeting synaptic pathology with a novel affinity mass spectrometry approach

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

α-Synuclein in Neurodegeneration-A Good Protein that may go Bad.